Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
The CHIC interview: Stéphane Bancel on Moderna's overnight transformation, the new timeline on vaccine development and his one regret in 2020
5 years ago
Publisher's note
Female entrepreneurs have long been underrepresented in biotech. An MIT team decided to find out why
5 years ago
Financing
Amgen CEO Bob Bradway takes home $20M+ pay package amid bang-up year for sales
5 years ago
The Endpoints 100 survey: CEOs changed the way biotechs operate during the pandemic. Things will never be the same again
5 years ago
Special
David Davidson’s R&D odyssey takes him out of bluebird to another biotech startup with big plans to transform therapy
5 years ago
Nearly 70% of Akcea's workforce is on the chopping block as Ionis executes major restructuring
5 years ago
Despite remdesivir approval and 2 big buyouts, Gilead CEO Dan O'Day sees pay fall 35% from 2019
5 years ago
Pharma
As Covid-19 vaccine was being developed, Moderna shelled out more than $1M for top executives' security
5 years ago
Pharma
Big Pharma R&D veteran with blockbuster credentials returns to his biotech roots as Prothena's new CMO
5 years ago
Martin Shkreli pushes back on lifetime public company ban from prison cell in bid to get back to business
5 years ago
Alcami appoints new CEO in Patrick Walsh, the executive who helped lead the CDMO's predecessor company
5 years ago
Manufacturing
It's time: After 19 years, legendary Koch Institute director Tyler Jacks passes the torch to Matthew Vander Heiden
5 years ago
Biotech pioneer and startup investor John Martin, who built Gilead into a powerhouse player, has died
5 years ago
After leaving Merck's C-suite, Mike Nally turns up at the helm of a Flagship machine learning company
5 years ago
Looking to leave Zolgensma data manipulation scandal behind, Brian Kaspar emerges at a new gene therapy player
5 years ago
Moncef Slaoui resigns from post-GlaxoSmithKline home Medicxi after harassment allegations
5 years ago
Gilead R&D chief William Lee to retire as Amgen I/O vet Flavius Martin takes the reins in April
5 years ago
Hunkering down on deals and racial diversity pledge amid pandemic, Giovanni Caforio took home $20M last year at Bristol Myers Squibb
5 years ago
Moncef Slaoui offers his 'deep regret' over sexual harassment charge — while getting the boot from biotech posts
5 years ago
Merck's big C-suite shuffle continues as Caroline Litchfield is tapped as new CFO
5 years ago
GlaxoSmithKline fires Moncef Slaoui as Galvani chair after ongoing probe substantiates sexual harassment allegations
5 years ago
One of the masterminds behind remdesivir, Gilead's Diana Brainard jumps ship to antiviral T cell player AlloVir
5 years ago
FDA's No. 2 Amy Abernethy to leave the agency in April
5 years ago
FDA+
José Baselga, acclaimed drug hunter, physician and AstraZeneca's pioneering cancer R&D chief, has died
5 years ago
First page
Previous page
59
60
61
62
63
64
65
Next page
Last page